CARRIE BRUNSON: Open Payments
NPI 1558072439 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 6 companies in 2025. Trend: 2023 $576 · 2024 $363 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Alkermes, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: INGREZZA, VRAYLAR, ARISTADA, LYBALVI, ABILIFY ASIMTUFII, Qelbree, CAPLYTA.
Industry payments across TX — which companies pay providers there.
